Most Read This Week
- Neoadjuvant and Adjuvant Therapy for Stage II and III Melanoma
- Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer Unsuitable for Cisplatin-Based Chemoradiation
- Weekly vs Three Weekly Cisplatin and Radical Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Everolimus Following Surgical Therapy for Renal Cell Carcinoma
- Ribociclib Plus Endocrine Therapy After Progression on Anti-Estrogen Therapy Plus CDK 4/6 Inhibition in Patients With Unresectable HR+/HER2− MBC
Recently Updated
- Maternal Deaths Up With Pregnancies Complicated by Cancer
- Updated Results of Belzutifan for Advanced RCC
- Tumor Genomic and Gut Microbiota Association With Clinical Outcomes in Newly Diagnosed Glioblastoma Treated With Atezolizumab, Temozolomide, and Radiation
- Everolimus Following Surgical Therapy for Renal Cell Carcinoma
- Intramuscular INO-5401 + INO-9012 With Cemiplimab in Newly Diagnosed Glioblastoma